Merck's Ebola Vaccine Granted Conditional Approval in the EU

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

...

Continue Reading

FDA Clears First Rapid Diagnostic Test for Ebola

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

Continue Reading

NIOSH Releases First Responder Illicit Drug Toolkit

The National Institute for Occupational Safety and Health (NIOSH) has released a new virtual toolkit to help first responders reduce their exposure to fentanyl and other illicit drugs. The toolkit provides resources to help keep first responders safe when arriving on a scene where illicit

...

Continue Reading

FLIR Aquires Tethered Drone Assets and Technology from Aria Insights

FLIR Systems, Inc. has announced that it has acquired the intellectual property (IP) and certain operating assets of Aria Insights, Inc. Terms of the deal are not being disclosed.

Previously known as CyPhy Works, Inc., Aria pioneered the development of tethered small unmanned aerial

...

Continue Reading

Ebola Therapy mAb114 Receives $14 million in Funding

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

...

Continue Reading

FDA Approve Smallpox/Monkeypox Vaccine

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

...

Continue Reading

MCDC Award $20 Million Contract for Development of Auto-Injector

Emergent BioSolutions Inc.  announced on September 25th that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) to treat nerve agent-induced seizures. Emergent’s device is being designed for intramuscular

...

Continue Reading

LLNL Nerve Agent Antidote Shows Great Potential

Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02. 

Their work has been showing great promise, and with somw refinement of

...

Continue Reading

HHS Funds an Additional Year of Ebola Vaccine Manufacturing

As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support

...

Continue Reading

OPCW report on Pueblo Chemical Agent-Destruction Pilot Plant

The OPCW has been visiting and reporting on the progress at the Pueblo Chemical Agent-Destruction Pilot Plant (PCAPP), in pursuance with decision C-16/DEC.11 “Final Extended Deadline of 29 April 2012”. 

 

The latest report from the OPCW visit in April 2019 is

...

Continue Reading

AntoXa awarded contract for anti-nerve agent enzyme

AntoXa Corporation has been awarded a contract with the Government of Canada to continue work on production of plant-made butyrylcholinesterase (BuChE), a protein that provides protection against toxic nerve agents such as sarin and soman.

The one-year contract, worth up to

...

Continue Reading

Avon Protection Awarded $254m U.S Army Contract

The U.S Department of Defense has awarded Avon Protection Systems a contract worth $245m for the production of the M53A1 respirator. 

The M53A1 was developed by Avon to counter military unique and domestic threats encountered on the modern battlefield, the global war on

...

Continue Reading

Emergent BioSolutions Initiates Phase 3 Clinical Study

Emergent BioSolutions Inc. recently announced the initiation of a Phase 3 trial to evaluate the lot consistency, immunogenicity, and safety of AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) following a two-dose schedule administered intramuscularly in healthy

...

Continue Reading

CEPI awards US$ 34M contract to CureVac to advance The RNA Printer

It was announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac AG, a biopharmaceutical company pioneering the field of mRNA-based vaccines, have announced a partnership agreement worth up to US$ 34 million for the ongoing development of The RNA Printer

...

Continue Reading

MyDefence introduces new anti-drone solution

For the past three years, MyDefence has been hard at work with development of a new type of anti-drone system that can effectively solve the problem of protecting large scale areas against the threat of drones. The system is named KNOX and is a customizable end-to-end

...

Continue Reading

Paul Boye supporting CBRN preparedness in Africa

Since September 2015 Paul Boyé Technologies has been managing the contract “Provision of specialized CBRN equipment for training first responders” in the scope of CoE project 50 to enhance CBRN preparedness and response capabilities of different countries of the African Atlantic Façade and

...

Continue Reading

US Army selects Med-Eng to protect EOD teams

Med-Eng, LLC, a company of The Safariland Group, has announced it has been awarded a four-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply the United States Army with its 2nd generation Advanced Bomb Suit (ABS II) to protect the lives of front line soldiers conducting

...

Continue Reading

FLIR receives $27.9 million order from DOD

FLIR Systems, Inc. has announced it has received a delivery order for 24 U.S. Army Chemical, Biological, Radiological, and Nuclear Dismounted Reconnaissance Sets, Kits, and Outfits (CBRN DR-SKO) systems.

The CBRN DR-SKO system is a set of mission-specific kits that characterize and

...

Continue Reading

Escape Respirator Challenge

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) announced today the launch of a $250K Challenge to develop concepts for an escape respirator.

The Escape Respirator Challenge seeks new concepts for an escape respirator solution. This challenge

...

Continue Reading

USAF fields new Joint Service Aircrew Mask

The US Air Force has started to field its Joint Service Aircrew Mask (JSAM) for helicopter aircraft as part of a larger effort to shield its personnel against contamination from weapons of mass destruction.

The JSAM provides better protection against CBRN contamination and is

...

Continue Reading

DuPont Nomex® Comfort

DuPont Safety & Construction today announced the launch of Nomex® Comfort, an innovative lightweight fabric combining the legendary flame resistant (FR) protection of Nomex® with enhanced comfort and breathability.

DuPont™ Nomex® is synonymous in the industry with the term protection and...

Continue Reading

Inovio’s Ebola Vaccine Provides 100% Protection

Following a recent pre-clinical study, Inovio have announced that their Ebola Vaccine, INO-4212 provided 100% protection following a challenge with a lethal dose of the Ebola virus.

An article in the Journal of Infectious Diseases highlights that regimens of Inovio’s INO-4212 vaccine

...

Continue Reading

New 1064nm handheld Raman analyzer

Rigaku ResQ CQL offers first responders, border protection, and law enforcement with an advanced method for identifying potential threats in an improved tactical form factor, thus improving functionality particularly in high stress environments. By combining the 1064nm Raman advantage with

...

Continue Reading

Our Current Sponsors